Please login to the form below

Not currently logged in
Email:
Password:

IMI

This page shows the latest IMI news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator

Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator

Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator. ... Meanwhile the topics on digital health and the blockchain highlight IMI’s commitment to working with all sectors involved in healthcare.’.

Latest news

More from news
Approximately 15 fully matching, plus 31 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare (part 2)

    She made major scientific contributions to neuroscience R&D within the pharmaceutical industry at GlaxoSmithkline, and also championed the vision for the Stevenage Bioscience Catalyst and theEuropean Innovative Medicines Initiative (IMI).

  • A quest for innovative solutions A quest for innovative solutions

    The innovative Medicines Initiative (IMI), with 5.3bn invested in 90 projects, is a barometer of the industry’s deep dive into technology at a time when ageing populations with multiple

  • Cubist: Meeting the challenge in antibiotics Cubist: Meeting the challenge in antibiotics

    There are a number of collaborations we have with biotech companies in Europe, but regarding the IMI collaboration, it is too early yet for discussion.”. ... Several other companies are signed up to the IMI's efforts in AMR, including GlaxoSmithKline,

  • Interview: Georg Toufar, Mundipharma Interview: Georg Toufar, Mundipharma

    of working with local academics, while the Innovative Medicines Initiative (IMI) is bringing EFPIA members together with academics and biotechs to research major public health problems.

  • Interview: Harvey Berger and Timothy Clackson, Ariad Interview: Harvey Berger and Timothy Clackson, Ariad

    clinical data or the EC-backed Innovative Medicines Initiative (IMI).

More from intelligence
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest appointments

  • Innovative Medicines Initiative appoints executive director Innovative Medicines Initiative appoints executive director

    Innovative Medicines Initiative (IMI) has named Pierre Meulien as executive director, effective from September. ... Pierre Meulien's invaluable experience will help IMI deliver on its ambitious objectives.”.

  • IMI picks Ipsen's Marc de Garidel to chair governing board IMI picks Ipsen's Marc de Garidel to chair governing board

    Its second-phase IMI 2 programme aims to develop next generation vaccines, medicines and treatments, such as new antibiotics. ... I am confident that his decades of experience working in the pharmaceutical sector will prove invaluable to IMI.”.

  • IMI appoints new chair of scientific committee IMI appoints new chair of scientific committee

    Prof Maria Beatriz da Silva Lima has been elected chair of the Scientific Committee of the Innovative Medicines Initiative (IMI). ... Finally, there is huge potential to expand the principles underlying IMI to the rest of the world.”.

  • Hans Lennernas joins board of CMO Recipharm Hans Lennernas joins board of CMO Recipharm

    Prof Lennernäs is currently a professor of biopharmaceuticals at Uppsala University in Sweden, where he manages an Innovative Medicines Initiative (IMI) project called OrBiTo, which aims to improve the delivery of

More from appointments
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • The heart of the matter - Part Three

    IMI GetReal, a consortium that includes EMA, HTA bodies, academia, patient organisations and pharma, aims to improve the efficiency of medicine development processes by developing a framework to assess the relative ... RCTs are still the gold standard

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics